Adco-Salterpyn Syrup 100ml

Adco Salterpyn Syrup 100ml

Acetaminophen (Salterpyn Syrup) is metabolized (eliminated by conversion to other chemicals) by the liver. Therefore drugs that increase the action of liver enzymes that metabolize Acetaminophen (Salterpyn Syrup) [for example, carbamazepine (Tegretol), isoniazid (INH, Nydrazid, Laniazid), rifampin (Rifamate, Rifadin, Rimactane)] reduce the levels of Acetaminophen (Salterpyn Syrup) and may decrease the action of Acetaminophen (Salterpyn Syrup). Doses of Acetaminophen (Salterpyn Syrup) greater than the recommended doses are toxic to the liver and may result in severe liver damage. The potential for Acetaminophen (Salterpyn Syrup) to harm the liver is increased when it is combined with alcohol or drugs that also harm the liver.

Cholestyramine (Questran) reduces the effect of Acetaminophen (Salterpyn Syrup) by decreasing its absorption into the body from the intestine. Therefore, Acetaminophen (Salterpyn Syrup) should be administered 3 to 4 hours after cholestyramine or one hour before cholestyramine.

Acetaminophen (Salterpyn Syrup) doses greater than 2275 mg per day may increase the blood thinning effect of warfarin (Coumadin) by an unknown mechanism. Therefore, prolonged administration or large doses of Acetaminophen (Salterpyn Syrup) should be avoided during warfarin therapy

Very rarely (and usually mild) skin rashes and palpitations. Sedation and dizziness may occur after the intake of the yellow (night) tablet. In this case it is not advisable for patients who drive or operate machinery at night. Therefore the yellow tablet is recommended at bedtime.